Please login to the form below

Not currently logged in
Email:
Password:

Ofev

This page shows the latest Ofev news and features for those working in and with pharma, biotech and healthcare.

Biogen loses another pipeline drug to toxicity concerns

Biogen loses another pipeline drug to toxicity concerns

In the interim, two drug treatments – Boehringer Ingelheim’s  Ofev(nintedanib) and Roche/Genentech’s  Esbriet(pirfenidone) – have been approved by the FDA for the disease and grown into blockbuster products

Latest news

More from news
Approximately 8 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....
Gilles Picard
As the opioid crisis grabs the headlines, the search for safe treatments continues
Indivior’s Gilles Picard charts a path to greater patient access and new therapies...

Infographics